Search

Your search keyword '"Peczkowska, Mariola"' showing total 132 results

Search Constraints

Start Over You searched for: Author "Peczkowska, Mariola" Remove constraint Author: "Peczkowska, Mariola"
132 results on '"Peczkowska, Mariola"'

Search Results

1. Maternal and fetal outcomes in phaeochromocytoma and pregnancy: a multicentre retrospective cohort study and systematic review of literature

2. Left Ventricular Structural and Functional Alterations in Patients With Pheochromocytoma/Paraganglioma Before and After Surgery

3. Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study

4. Systematic and Multidisciplinary Evaluation of Fibromuscular Dysplasia Patients Reveals High Prevalence of Previously Undetected Fibromuscular Dysplasia Lesions and Affects Clinical Decisions: The ARCADIA-POL Study

6. Supplementary Table 2 from Clinical Predictors for Germline Mutations in Head and Neck Paraganglioma Patients: Cost Reduction Strategy in Genetic Diagnostic Process as Fall-Out

7. Other Supporting Colleagues from Clinical Predictors for Germline Mutations in Head and Neck Paraganglioma Patients: Cost Reduction Strategy in Genetic Diagnostic Process as Fall-Out

8. Supplementary Table 1 from Clinical Predictors for Germline Mutations in Head and Neck Paraganglioma Patients: Cost Reduction Strategy in Genetic Diagnostic Process as Fall-Out

9. Data from Clinical Predictors for Germline Mutations in Head and Neck Paraganglioma Patients: Cost Reduction Strategy in Genetic Diagnostic Process as Fall-Out

10. Supplementary Table 1 Legends and References from Clinical Predictors for Germline Mutations in Head and Neck Paraganglioma Patients: Cost Reduction Strategy in Genetic Diagnostic Process as Fall-Out

12. Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based study

13. Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed Prevention

16. Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene

17. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations

18. Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma

19. Maternal and fetal outcomes in phaeochromocytoma and pregnancy: a multicentre retrospective cohort study and systematic review of literature

20. Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10

21. Primary hyperparathyroidism as first manifestation in multiple endocrine neoplasia type 2A: an international multicenter study

23. Primary hyperparathyroidism as first manifestation in MEN 2A: an international multicenter study

24. Germline NF1 Mutational Spectra and Loss-of-Heterozygosity Analyses in Patients with Pheochromocytoma and Neurofibromatosis Type 1

28. Comparison of Pheochromocytoma-Specific Morbidity and Mortality Among Adults With Bilateral Pheochromocytomas Undergoing Total Adrenalectomy vs Cortical-Sparing Adrenalectomy

29. Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study.

30. Preventive medicine of von Hippel–Lindau disease-associated pancreatic neuroendocrine tumors

31. 65 YEARS OF THE DOUBLE HELIX: Genetics informs precision practice in the diagnosis and management of pheochromocytoma

32. Preventive medicine of von Hippel-Lindau disease-associated pancreatic neuroendocrine tumors

33. 65 YEARS OF THE DOUBLE HELIX Genetics informs precision practice in the diagnosis and management of pheochromocytoma

34. The penetrance of MEN2 pheochromocytoma is not only determined by RET mutations

35. Prevention Medicine in Bilateral Phaeochromocytoma

36. The penetrance of MEN2 pheochromocytoma is not only determined by RET mutations

37. The penetrance of MEN2 pheochromocytoma is not only determined by RET mutations

38. The penetrance of MEN2 pheochromocytoma is not only determined by RET mutations

39. Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based study

40. Genetics informs precision practice in the diagnosis and management of pheochromocytoma.

41. A registry-based study of thyroid paraganglioma: histological and genetic characteristics

42. DISCREPANCIES IN THE OUTCOME OF PLASMA ALDOSTERONE LEVELS ASSESSED BY IMMUNOASSAY AND MASS SPECTROMETRY - CLINICAL RELEVANCE FOR THE DIAGNOSIS OF PRIMARY HYPERALDOSTERONISM.

43. Long-term prognosis of patients with pediatric pheochromocytoma

44. Biochemical diagnosis of phaeochromocytoma using plasma‐free normetanephrine, metanephrine and methoxytyramine: importance of supine sampling under fasting conditions

45. Systematic comparison of sporadic and syndromic pancreatic islet cell tumors

46. Clinical Predictors for Germline Mutations in Head and Neck Paraganglioma Patients: Cost Reduction Strategy in Genetic Diagnostic Process as Fall-Out

47. GermlineNF1Mutational Spectra and Loss-of-Heterozygosity Analyses in Patients with Pheochromocytoma and Neurofibromatosis Type 1

50. Pheochromocytoma of the Urinary Bladder Coexisting with Another Extra-adrenal Tumour - Case Report of a 19-year-old Male Patient

Catalog

Books, media, physical & digital resources